|
|
Transcode Therapeutics Inc (NASDAQ: RNAZ) |
|
*Market share is calculated based on total revenue.
News about Transcode Therapeutics Inc Contracts |
October 10, 2024
Unlocking the Secrets of MicroRNA: TransCode Therapeutics Journey Toward Combatting Metastatic Cancer In the ever-evolving world of biotech innovation, TransCode Therapeutics is making bold strides with its groundbreaking microRNA-targeted technology. Their flagship candidate, TTX-MC138, is shining a promising light on the treatment of metastatic cancer. At the core of this pioneering work are recent milestones and revelations that not only highlight the potential of TTX-MC138 but also mark significant steps forward for TransCode Therapeutics as a rising star in the biopharmaceutical field. 1. Completion of Initial Dosing in Phase 1 Clinical Trial TransCode Therapeutics recently announced the successful dos...
|
May 29, 2024
The field of oncology has seen remarkable advancements in recent years, particularly with the emergence of RNA therapeutics. Among the notable contributors in this area is TransCode Therapeutics, Inc. (NASDAQ: RNAZ), an innovative RNA oncology company committed to revolutionizing cancer treatment using RNA-based therapeutic candidates. In a recent announcement, TransCode Therapeutics reported encouraging results from a first-in-human clinical study involving their groundbreaking lead candidate, TTX-MC138. Additionally, the company is set to present Phase 0 data during the prestigious San Antonio Breast Cancer Symposium, which is scheduled to be held from December 5-9, 2023.Unveiling Positive Data from First-...
|
Publicly Traded Peers of Transcode Therapeutics Inc
Novavax inc
Share Performance
-12.07%
30 Days
|
Novavax inc
Profile
Novavax Inc is a biotechnology company focused on the discovery, development, and commercialization of novel vaccines. They aim to leverage their proprietary recombinant nanoparticle vaccine technology platform to address a wide range of infectious diseases. By collaborating with partners and conducting clinical trials, Novavax works towards bringing innovative vaccines to the global market.
More about Novavax inc 's Market Share
|
Moderna Inc
Share Performance
-3.07%
30 Days
|
Moderna Inc
Profile
Moderna Inc's business model revolves around the development and commercialization of mRNA-based therapeutics and vaccines. They focus on using messenger RNA (mRNA) technology to create drugs that can help prevent and treat various diseases.
More about Moderna Inc 's Market Share
|
Biontech Se
Share Performance
-7.61%
This Year
|
Biontech Se
Profile
Biontech SE's business model focuses on the development and commercialization of novel mRNA-based immunotherapies for various diseases, including cancer.
More about Biontech Se's Market Share
|
Alnylam Pharmaceuticals Inc
Share Performance
+0.56%
Over The Past 5 Days
|
Alnylam Pharmaceuticals Inc
Profile
Alnylam Pharmaceuticals Inc's business model focuses on developing and commercializing RNA interference (RNAi) therapeutics.
More about Alnylam Pharmaceuticals Inc 's Market Share
|
Regeneron Pharmaceuticals Inc
Share Performance
-3.69%
Over The Past 5 Days
|
Regeneron Pharmaceuticals Inc
Profile
Regeneron Pharmaceuticals Inc operates a business model centered on the discovery and commercialization of cutting-edge biopharmaceuticals, particularly in the fields of ophthalmology, oncology, immunology, and rare diseases. They leverage their strong research and development capabilities, including their proprietary technologies, to create innovative therapies that address unmet medical needs. Additionally, Regeneron forms strategic collaborations and partnerships to enhance their development pipeline and expand market access for their products.
More about Regeneron Pharmaceuticals Inc 's Market Share
|
Sarepta Therapeutics Inc
Share Performance
-48.23%
30 Days
|
Sarepta Therapeutics Inc
Profile
Sarepta Therapeutics Inc's business model centers around the research, development, and commercialization of innovative genetic medicines for rare diseases, with a particular focus on Duchenne muscular dystrophy (DMD).
More about Sarepta Therapeutics Inc 's Market Share
|
Editas Medicine Inc
Share Performance
+69.47%
This Year
|
Editas Medicine Inc
Profile
Editas Medicine Inc.'s business model revolves around developing and commercializing transformative genome editing technologies to treat serious diseases.
More about Editas Medicine Inc 's Market Share
|
Crispr Therapeutics Ag
Share Performance
+6.99%
Over The Past 5 Days
|
Crispr Therapeutics Ag
Profile
CRISPR Therapeutics AG is a biopharmaceutical company focused on developing transformative gene-based medicines using its CRISPR/Cas9 gene-editing platform. They aim to leverage the potential of CRISPR to treat severe genetic diseases by directly modifying genes within the body's cells. The company collaborates with partners, conducts research and development of their therapeutics, and ultimately aims to bring their innovative treatments to market.
More about Crispr Therapeutics Ag's Market Share
|
Uniqure N v
Share Performance
+3.72%
This Quarter
|
Uniqure N v
Profile
Uniqure N.V's business model revolves around developing and commercializing gene therapies to address rare genetic diseases.
More about Uniqure N v 's Market Share
|
Wave Life Sciences Ltd
Share Performance
-31.49%
This Quarter
|
Wave Life Sciences Ltd
Profile
Wave Life Sciences Ltd is a biotechnology company focused on developing and commercializing nucleic acid therapies for rare genetic diseases. Their business model revolves around utilizing their proprietary chemistry platform to design and create custom-built, targeted medicines that can potentially address a wide range of genetic disorders. They aim to bring these therapies through preclinical and clinical development stages and ultimately deliver innovative treatments to patients in need.
More about Wave Life Sciences Ltd 's Market Share
|
Zyversa Therapeutics Inc
Share Performance
+19.03%
30 Days
|
Zyversa Therapeutics Inc
Profile
Zyversa Therapeutics Inc's business model revolves around developing innovative therapies and treatments for various medical conditions.
More about Zyversa Therapeutics Inc 's Market Share
|
Verve Therapeutics Inc
Share Performance
+152.51%
30 Days
|
Verve Therapeutics Inc
Profile
Verve Therapeutics Inc is a biotechnology company specialized in developing transformative medicines that could permanently prevent cardiovascular diseases through gene editing technology. Their business model revolves around leveraging cutting-edge gene editing techniques to develop novel therapeutics targeting specific genes associated with heart diseases. By utilizing this approach, Verve aims to provide long-term solutions for individuals at risk of cardiovascular ailments, addressing a significant unmet need in the healthcare industry.
More about Verve Therapeutics Inc 's Market Share
|
Precigen Inc
Share Performance
-4.61%
Over The Past 5 Days
|
Precigen Inc
Profile
Precigen Inc is a biotechnology company that focuses on the development and commercialization of innovative genetic therapies. Their business model revolves around leveraging their proprietary technologies and expertise in gene editing and synthetic biology to create transformative medical solutions. With a strong emphasis on research and development, Precigen aims to bring cutting-edge genetic therapies to market and address critical unmet medical needs.
More about Precigen Inc 's Market Share
|
Atreca inc
Share Performance
-57.55%
This Quarter
|
Atreca inc
Profile
Atreca Inc operates on a unique business model focused on developing novel therapeutics by leveraging its proprietary Immune Repertoire Capture (IRC) technology to analyze and identify antibodies present in patients with specific diseases, ultimately enabling the development of targeted therapies.
More about Atreca inc 's Market Share
|
23andme Holding Co
Share Performance
-16.95%
Over The Past 5 Days
|
23andme Holding Co
Profile
23andMe Holding Co operates as a direct-to-consumer genetic testing company. Their business model primarily revolves around selling DNA testing kits to individuals, who can then provide a saliva sample and receive reports on their genetic ancestry, health predispositions, and other genetic traits. The company generates revenue by charging customers for the testing kits, as well as offering additional subscription-based services for ongoing access to updated reports and insights.
More about 23andme Holding Co 's Market Share
|
Generation Bio Co
Share Performance
-24.47%
This Quarter
|
Generation Bio Co
Profile
Generation Bio Co is a biotechnology company that focuses on developing innovative genetic medicines using its proprietary non-viral gene therapy platform. The company's business model involves leveraging its expertise in gene editing and delivery technologies to create transformative treatments for a wide range of genetic diseases. Generation Bio Co aims to collaborate with pharmaceutical partners to advance its pipeline and bring life-changing therapies to patients worldwide.
More about Generation Bio Co 's Market Share
|
Bio path Holdings inc
Share Performance
+23.53%
30 Days
|
Bio path Holdings inc
Profile
Bio path Holdings Inc is a biotechnology company focused on developing RNA-based therapeutics for the treatment of diseases such as cancer. Their business model involves researching, developing, and commercializing these therapies to provide improved treatment options for patients.
More about Bio path Holdings inc's Market Share
|
Cell Source Inc
Share Performance
+2.69%
Over The Past 5 Days
|
Cell Source Inc
Profile
Cell Source Inc is a biotechnology company that specializes in the development and commercialization of innovative treatments for diseases. Their business model focuses on leveraging advanced cell therapy technologies to create personalized and regenerative therapies for patients. By partnering with research institutions and healthcare organizations, Cell Source aims to bring their cutting-edge solutions to the market, ultimately improving health outcomes and patient quality of life.
More about Cell Source Inc 's Market Share
|
Synlogic Inc
Share Performance
-10.64%
This Year
|
Synlogic Inc
Profile
Synlogic Inc's business model revolves around utilizing synthetic biology to develop innovative microbial engineering solutions. They focus on developing Synthetic Biotic medicines, which are living medicines designed to treat diseases by targeting specific metabolic or immuno-inflammatory pathways in the body.
More about Synlogic Inc 's Market Share
|
Abeona Therapeutics Inc
Share Performance
-4.38%
Over The Past 5 Days
|
Abeona Therapeutics Inc
Profile
Abeona Therapeutics Inc is a biopharmaceutical company focused on developing gene and cell therapies for rare genetic diseases. Their business model revolves around identifying and acquiring promising technologies, conducting pre-clinical and clinical research, and eventually bringing these therapies to the market. They collaborate with academic institutions, medical centers, and patient advocacy groups to advance their pipeline and provide solutions for currently untreatable genetic disorders.
More about Abeona Therapeutics Inc 's Market Share
|
Fulcrum Therapeutics Inc
Share Performance
+2.12%
Over The Past 5 Days
|
Fulcrum Therapeutics Inc
Profile
Fulcrum Therapeutics Inc operates as a biopharmaceutical company that focuses on developing personalized therapies for genetically defined diseases. Their business model involves leveraging their proprietary product engine to identify and target specific gene regulatory networks to address the root causes of diseases.
More about Fulcrum Therapeutics Inc 's Market Share
|
Tango Therapeutics Inc
Share Performance
+193.18%
This Quarter
|
Tango Therapeutics Inc
Profile
Tango Therapeutics Inc is a biotechnology company that focuses on developing cancer therapies using DNA sequencing and computational biology. Their business model revolves around discovering and developing precision medicines by leveraging their expertise in genomics and biology to target specific cancer vulnerabilities.
More about Tango Therapeutics Inc 's Market Share
|
Sigilon Therapeutics Inc
Share Performance
+6,413.04%
This Year
|
Sigilon Therapeutics Inc
Profile
Sigilon Therapeutics Inc is a biotechnology company that focuses on developing novel therapies using advanced cell engineering and implantable devices to treat chronic diseases.
More about Sigilon Therapeutics Inc 's Market Share
|
Bridgebio Pharma Inc
Share Performance
+52.52%
One Year
|
Bridgebio Pharma Inc
Profile
BridgeBio Pharma Inc is a biopharmaceutical company that focuses on developing and commercializing precision medicines for genetic diseases and cancers. Their business model involves identifying and acquiring early-stage drug candidates, conducting clinical trials, and partnering with other companies for commercialization.
More about Bridgebio Pharma Inc 's Market Share
|
Novaccess Global Inc
Share Performance
+33.33%
Over The Past 5 Days
|
Novaccess Global Inc
Profile
Novaccess Global Inc's business model revolves around providing innovative access control solutions for various industries. Their offerings range from physical access control systems to cloud-based security solutions, helping organizations enhance their security measures and streamline access management processes.
More about Novaccess Global Inc's Market Share
|
Nektar Therapeutics
Share Performance
-14.04%
30 Days
|
Nektar Therapeutics
Profile
Nektar Therapeutics operates under a business model focused on developing and commercializing innovative medicines. The company's approach involves utilizing its proprietary technology platforms to create novel therapeutic candidates and establish partnerships with pharmaceutical and biotechnology firms for clinical development and commercialization. Nektar Therapeutics aims to bring transformative therapies to market that address significant unmet medical needs.
More about Nektar Therapeutics's Market Share
|
Cytokinetics Incorporated
Share Performance
-39.41%
One Year
|
Cytokinetics Incorporated
Profile
Cytokinetics Incorporated is a biopharmaceutical company with a business model centered around the discovery and development of novel muscle activators. They strive to improve the lives of patients with debilitating diseases by focusing on the development of potentially life-changing therapies. Cytokinetics aims to achieve commercial success by leveraging its expertise in muscle biology and utilizing strategic collaborations to bring their innovative therapies to market.
More about Cytokinetics Incorporated's Market Share
|
Arcus Biosciences Inc
Share Performance
-1.82%
30 Days
|
Arcus Biosciences Inc
Profile
Arcus Biosciences Inc is a biotechnology company that focuses on developing immuno-oncology therapies. Their business model revolves around discovering and developing novel small molecule and antibody therapeutics to target various cancer indications. They aim to combine their extensive understanding of the immune system with innovative technology platforms to create effective treatments for patients with cancer.
More about Arcus Biosciences Inc 's Market Share
|
Arvinas Inc
Share Performance
-14.97%
This Quarter
|
Arvinas Inc
Profile
Arvinas Inc's business model revolves around developing novel therapies based on protein degradation technology to address unmet medical needs.
More about Arvinas Inc 's Market Share
|
Fibrogen Inc
Share Performance
-12.85%
Over The Past 5 Days
|
Fibrogen Inc
Profile
Fibrogen Inc's business model focuses on the development and commercialization of innovative therapeutics for unmet medical needs. They aim to discover and create treatments by leveraging their expertise in fibrosis and tissue regeneration. Fibrogen Inc collaborates with strategic partners and utilizes its extensive research and development capabilities to bring these therapies to market and improve the lives of patients.
More about Fibrogen Inc 's Market Share
|
Pharming Group N v
Share Performance
+18.28%
This Quarter
|
Pharming Group N v
Profile
Pharming Group N.V. operates on a business model focused on the development, production, and commercialization of innovative therapeutic products for the treatment of rare diseases and unmet medical needs. The company primarily generates revenue by selling its approved products in various geographic markets and through strategic collaborations with pharmaceutical partners. Pharming Group N.V. also engages in research and development activities to expand its product pipeline and explore potential new treatments.
More about Pharming Group N v 's Market Share
|
Morphosys Ag
Share Performance
+1.94%
Over The Past 5 Days
|
Morphosys Ag
Profile
Morphosys Ag's business model revolves around the development and commercialization of therapeutic antibodies.
More about Morphosys Ag's Market Share
|
Atea Pharmaceuticals Inc
Share Performance
+2.85%
Over The Past 5 Days
|
Atea Pharmaceuticals Inc
Profile
Atea Pharmaceuticals Inc. is a biopharmaceutical company that focuses on developing antiviral therapeutics to combat infectious diseases. Their business model revolves around identifying and advancing novel drug candidates that target specific viral mechanisms and inhibit their replication. This includes conducting preclinical and clinical trials, engaging in strategic partnerships, and ultimately bringing effective antiviral treatments to market.
More about Atea Pharmaceuticals Inc 's Market Share
|
Corcept Therapeutics Inc
Share Performance
+137.62%
One Year
|
Corcept Therapeutics Inc
Profile
Corcept Therapeutics Inc operates using a business model that focuses primarily on the research, development, and commercialization of pharmaceutical products. The company aims to discover and develop medications for conditions related to cortisol dysregulation, with a specific focus on Cushing's syndrome and psychiatric disorders. Additionally, Corcept Therapeutics Inc aims to ensure the successful commercialization of their products through collaborations and partnerships with other organizations to reach a wider market.
More about Corcept Therapeutics Inc's Market Share
|
Alpine Immune Sciences Inc
Share Performance
+0.03%
Over The Past 5 Days
|
Alpine Immune Sciences Inc
Profile
Alpine Immune Sciences Inc is a biotechnology company focused on developing immunotherapies to treat cancer and autoimmune diseases. Their business model involves identifying unique protein targets and using their proprietary technology platform to engineer and develop novel therapeutic antibodies that modulate the immune system. They aim to partner with pharmaceutical companies for the clinical development and commercialization of their product candidates.
More about Alpine Immune Sciences Inc 's Market Share
|
Contrafect Corporation
Share Performance
-80.77%
30 Days
|
Contrafect Corporation
Profile
ContraFect Corporation is a biotechnology company that focuses on the development of protein and antibody-based therapies to treat drug-resistant infectious diseases.
More about Contrafect Corporation's Market Share
|
Moonlake Immunotherapeutics
Share Performance
+12.96%
30 Days
|
Moonlake Immunotherapeutics
Profile
Moonlake Immunotherapeutics's business model revolves around the development and commercialization of innovative immunotherapies for the treatment of diseases.
More about Moonlake Immunotherapeutics's Market Share
|
Rocket Pharmaceuticals Inc
Share Performance
-67.97%
This Quarter
|
Rocket Pharmaceuticals Inc
Profile
Rocket Pharmaceuticals Inc is a biotechnology company that focuses on the development and commercialization of gene therapies for rare and devastating diseases.
More about Rocket Pharmaceuticals Inc 's Market Share
|
Centessa Pharmaceuticals Plc
Share Performance
-1.51%
30 Days
|
Centessa Pharmaceuticals Plc
Profile
Centessa Pharmaceuticals Plc operates as a biopharmaceutical company that focuses on the discovery and development of innovative medicines. Their business model centers around leveraging a decentralized approach, with multiple subsidiary companies working autonomously to accelerate the research and development of potential therapeutics across various disease areas. By bringing together diverse expertise and resources, Centessa aims to efficiently advance breakthrough therapies and deliver impactful solutions to patients in need.
More about Centessa Pharmaceuticals Plc's Market Share
|
Xilio Therapeutics inc
Share Performance
-12.85%
This Quarter
|
Xilio Therapeutics inc
Profile
Xilio Therapeutics Inc is a biotechnology company focused on developing and commercializing novel immunotherapies to treat cancer.
More about Xilio Therapeutics inc 's Market Share
|
Lianbio
Share Performance
-93.33%
30 Days
|
Lianbio
Profile
LianBio is a biopharmaceutical company that focuses on accelerating the development and commercialization of innovative medicines in the Chinese market. They collaborate with global partners to identify and acquire promising drug candidates, providing them with regulatory expertise and commercialization capabilities. By leveraging their deep understanding of the Chinese healthcare landscape, LianBio aims to bridge the gap between global innovation and Chinese patient needs.
More about Lianbio's Market Share
|
Prelude Therapeutics Inc
Share Performance
-4.40%
30 Days
|
Prelude Therapeutics Inc
Profile
Prelude Therapeutics Inc is a biopharmaceutical company that focuses on developing innovative small molecule therapeutic products for cancer treatment. Their business model revolves around conducting extensive research and employing a target discovery engine to identify and validate potential drug targets. By using a combination of proprietary technologies and collaborations with academic institutions, Prelude Therapeutics aims to develop and commercialize novel oncology therapies to address unmet medical needs.
More about Prelude Therapeutics Inc's Market Share
|
Eqrx Inc
Share Performance
-57.06%
One Year
|
Eqrx Inc
Profile
Eqrx Inc is a pharmaceutical company that focuses on creating affordable and accessible medication. They employ an innovative business model that combines research and development with scientific expertise to develop generic alternatives to the high-priced drugs in the market. By bypassing the traditional pharmaceutical pricing system, Eqrx aims to make essential medications more affordable for patients and healthcare providers.
More about Eqrx Inc 's Market Share
|
Matinas Biopharma Holdings Inc
Share Performance
-88.14%
One Year
|
Matinas Biopharma Holdings Inc
Profile
Matinas Biopharma Holdings Inc operates as a clinical-stage biopharmaceutical company. Their business model centers around developing therapeutics through the utilization of lipid nano-crystal (LNC) platform technologies. These technologies enable the effective delivery of drugs to improve patient outcomes in various diseases and conditions such as fungal infections, viral infections, and cancer.
More about Matinas Biopharma Holdings Inc 's Market Share
|
Lexicon Pharmaceuticals Inc
Share Performance
+106.50%
This Quarter
|
Lexicon Pharmaceuticals Inc
Profile
Lexicon Pharmaceuticals Inc is a biopharmaceutical company that focuses on the discovery and development of innovative drugs. Their business model revolves around identifying potential drug targets, conducting research and preclinical studies to validate these targets, and subsequently developing drugs through clinical trials for various therapeutic areas. They also collaborate with pharmaceutical companies for joint development and commercialization efforts, aiming to bring these drugs to market and improve patient outcomes.
More about Lexicon Pharmaceuticals Inc 's Market Share
|
Legend Biotech Corporation
Share Performance
-7.68%
Over The Past 5 Days
|
Legend Biotech Corporation
Profile
Legend Biotech Corporation is a biotech company focused on developing innovative cell therapies and gene therapies to address unmet medical needs in various diseases.
More about Legend Biotech Corporation's Market Share
|
Opko Health Inc
Share Performance
+1.57%
30 Days
|
Opko Health Inc
Profile
Opko Health Inc is a biotechnology and pharmaceutical company that operates through various business segments. The company primarily focuses on diagnostics, developing and commercializing novel diagnostic tests for various conditions. Additionally, Opko Health engages in the production and sale of pharmaceuticals and vaccines, as well as the research and development of new medical technologies.
More about Opko Health Inc 's Market Share
|
Emergent Biosolutions Inc
Share Performance
+8.74%
This Quarter
|
Emergent Biosolutions Inc
Profile
Emergent Biosolutions Inc's business model focuses on developing and manufacturing specialty products for the prevention and treatment of public health threats.
More about Emergent Biosolutions Inc 's Market Share
|
United Therapeutics Corporation
Share Performance
-5.82%
30 Days
|
United Therapeutics Corporation
Profile
United Therapeutics Corporation's business model revolves around the development and commercialization of innovative therapeutics for treating rare diseases and chronic conditions. They focus on researching, manufacturing, marketing, and distributing their specialized pharmaceutical and medical products to healthcare providers and patients globally.
More about United Therapeutics Corporation's Market Share
|
Dmk Pharmaceuticals Corporation
Share Performance
-57.04%
Over The Past 5 Days
|
Dmk Pharmaceuticals Corporation
Profile
DMK Pharmaceuticals Corporation has a business model focused on the development, manufacturing, and distribution of pharmaceutical products.
More about Dmk Pharmaceuticals Corporation's Market Share
|
Innovation1 Biotech Inc
Share Performance
0.00%
30 Days
|
Innovation1 Biotech Inc
Profile
The business model of Innovation1 Biotech Inc involves developing and commercializing innovative biotechnological products and solutions for various industries. The company focuses on research, development, and manufacturing, aiming to provide cutting-edge biotech solutions that meet the needs of diverse markets.
More about Innovation1 Biotech Inc 's Market Share
|
Actavia Life Sciences Inc
Share Performance
0.00%
30 Days
|
Actavia Life Sciences Inc
Profile
Rasna Therapeutics Inc is a biotechnology company that focuses on developing innovative therapies for the treatment of cancer and other diseases. Their business model revolves around leveraging cutting-edge research and technology to discover and develop novel drug candidates. They aim to partner with pharmaceutical companies or license their intellectual property to bring their therapies to market and ultimately improve patient outcomes.
More about Actavia Life Sciences Inc 's Market Share
|
Evelo Biosciences Inc
Share Performance
0.00%
This Year
|
Evelo Biosciences Inc
Profile
Evelo Biosciences Inc is a biotechnology company focused on developing therapies for the treatment of various diseases. Their business model revolves around harnessing the potential of the body's own immune system through the development of monoclonal microbials. These microbials are designed to interact with the gut to elicit specific therapeutic effects, offering a novel approach to addressing medical conditions.
More about Evelo Biosciences Inc 's Market Share
|
180 Life Sciences Corp
Share Performance
-23.52%
This Quarter
|
180 Life Sciences Corp
Profile
180 Life Sciences Corp is a biotechnology company engaged in the research and development of novel drugs that target inflammation and fibrosis to address various diseases such as fibrosis, inflammation, and pain.
More about 180 Life Sciences Corp's Market Share
|
Tiziana Life Sciences Ltd
Share Performance
+0.65%
Over The Past 5 Days
|
Tiziana Life Sciences Ltd
Profile
Tiziana Life Sciences Ltd's business model focuses on the development and commercialization of innovative therapeutics in the field of immunology and oncology.
More about Tiziana Life Sciences Ltd's Market Share
|
Viracta Therapeutics Inc
Share Performance
-38.80%
This Quarter
|
Viracta Therapeutics Inc
Profile
Viracta Therapeutics Inc is a biopharmaceutical company focused on developing targeted therapies for viral-associated cancers. The company aims to advance research, develop innovative treatments, and commercialize products to improve the lives of patients suffering from these types of cancers.
More about Viracta Therapeutics Inc 's Market Share
|
Nanoviricides inc
Share Performance
-21.43%
One Year
|
Nanoviricides inc
Profile
Nanoviricides Inc. is a pharmaceutical company that operates on a business model based on the development and commercialization of nanomedicines.
More about Nanoviricides inc 's Market Share
|
Hcw Biologics Inc
Share Performance
-84.20%
One Year
|
Hcw Biologics Inc
Profile
HCW Biologics Inc is a biotechnology company that operates on a business model focused on the research, development, and commercialization of biologic therapies. The company primarily focuses on developing and manufacturing novel biological products for various medical conditions. Their business model involves collaboration with industry partners, conducting clinical trials, and securing regulatory approvals for the commercialization of their biologic therapies.
More about Hcw Biologics Inc 's Market Share
|
Renovorx Inc
Share Performance
+12.20%
30 Days
|
Renovorx Inc
Profile
Renovorx Inc is a medical technology company specializing in the development of innovative treatments for cardiovascular diseases. Their business model focuses on creating and commercializing minimally invasive therapies for patients suffering from conditions like myocardial infarction and heart failure. By leveraging cutting-edge medical devices and procedures, Renovorx aims to provide effective and efficient treatments that can significantly improve patient outcomes and quality of life.
More about Renovorx Inc 's Market Share
|
Indaptus Therapeutics Inc
Share Performance
-68.22%
This Year
|
Indaptus Therapeutics Inc
Profile
Indaptus Therapeutics Inc's business model focuses on developing and commercializing innovative therapies in the healthcare industry.
More about Indaptus Therapeutics Inc 's Market Share
|
Esperion Therapeutics Inc
Share Performance
-51.36%
This Year
|
Esperion Therapeutics Inc
Profile
Esperion Therapeutics Inc's business model focuses on the development and commercialization of innovative therapies for addressing cardiovascular diseases.
More about Esperion Therapeutics Inc 's Market Share
|
Palatin Technologies Inc
Share Performance
-92.76%
This Year
|
Palatin Technologies Inc
Profile
Palatin Technologies Inc has a business model focused on developing and commercializing innovative medicines in the field of reproductive healthcare and sexual dysfunction. The company's revenue streams primarily come from partnerships, licensing agreements, and product sales.
More about Palatin Technologies Inc 's Market Share
|
Altamira Therapeutics Ltd
Share Performance
-88.89%
One Year
|
Altamira Therapeutics Ltd
Profile
Altamira Therapeutics Ltd's business model revolves around developing and commercializing innovative therapeutics.
More about Altamira Therapeutics Ltd 's Market Share
|
Leap Therapeutics Inc
Share Performance
-88.29%
This Year
|
Leap Therapeutics Inc
Profile
Leap Therapeutics Inc. is a biopharmaceutical company with a business model focused on discovering and developing targeted therapies for cancer. They aim to leverage their expertise in identifying novel targets and developing antibody-based therapies to address unmet medical needs in oncology. By advancing their pipeline of innovative drugs, they seek to provide effective treatment options for patients and create value for stakeholders in the pharmaceutical industry.
More about Leap Therapeutics Inc 's Market Share
|
Cellectar Biosciences Inc
Share Performance
-89.80%
One Year
|
Cellectar Biosciences Inc
Profile
Cellectar Biosciences Inc is a biopharmaceutical company that focuses on the development of targeted cancer therapies. They utilize their proprietary drug conjugation platform to create targeted small molecules that can selectively bind and deliver radioactive isotopes directly to cancer cells. Their business model revolves around developing and commercializing these innovative therapies for the treatment of various types of cancer, aiming to improve patient outcomes and potentially revolutionize cancer treatment.
More about Cellectar Biosciences Inc 's Market Share
|
Xenetic Biosciences Inc
Share Performance
-37.67%
One Year
|
Xenetic Biosciences Inc
Profile
Xenetic Biosciences Inc is a biopharmaceutical company that focuses on developing personalized therapeutics with the potential to improve patient outcomes. The company employs a business model centered around leveraging its proprietary drug development platform to partner with pharmaceutical companies and advance novel drug candidates through preclinical and clinical stages.
More about Xenetic Biosciences Inc 's Market Share
|
Xbiotech Inc
Share Performance
-51.55%
One Year
|
Xbiotech Inc
Profile
Xbiotech Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic antibodies. They seek to address unmet medical needs by leveraging their proprietary True Human antibody technology.
More about Xbiotech Inc 's Market Share
|
Journey Medical Corp
Share Performance
+25.68%
One Year
|
Journey Medical Corp
Profile
Journey Medical Corporation is a pharmaceutical and medical device company that specializes in developing and commercializing innovative products for dermatology and aesthetics. Their business model revolves around conducting research and development to create new products, acquiring the necessary regulatory approvals, and partnering with healthcare professionals to effectively distribute and market these products. By focusing on dermatology and aesthetics, Journey Medical Corporation aims to address unmet medical needs and provide cutting-edge solutions to improve patient outcomes in these fields.
More about Journey Medical Corp's Market Share
|
Coya Therapeutics Inc
Share Performance
-3.59%
This Year
|
Coya Therapeutics Inc
Profile
Coya Therapeutics Inc's business model focuses on developing and providing therapeutic solutions for various medical conditions or diseases.
More about Coya Therapeutics Inc 's Market Share
|
Avalo Therapeutics Inc
Share Performance
-39.43%
This Quarter
|
Avalo Therapeutics Inc
Profile
Avalo Therapeutics Inc is a biotechnology company that focuses on developing novel cancer therapies. Their business model revolves around discovering and advancing targeted therapeutics using their proprietary platform technology. They aim to bring innovative treatments to patients by employing a combination of scientific expertise, strategic collaborations, and clinical development.
More about Avalo Therapeutics Inc 's Market Share
|
Mineralys Therapeutics Inc
Share Performance
-20.09%
This Quarter
|
Mineralys Therapeutics Inc
Profile
Mineralys Therapeutics Inc is a biotechnology company that follows the business model of developing and commercializing novel therapeutics for various diseases. They focus on discovering and advancing small molecule drugs based on innovative research approaches. Their business model is centered around conducting preclinical and clinical trials, obtaining regulatory approvals, and ultimately bringing their therapeutic products to market for improved patient outcomes.
More about Mineralys Therapeutics Inc 's Market Share
|
Grifols Sa
Share Performance
+16.31%
This Year
|
Grifols Sa
Profile
Grifols SA operates a business model that focuses on plasma-derived medicine production and commercialization, including plasma collection, testing, and fractionation, as well as the development of diagnostic equipment and transfusion medicine. Their core activities involve the extraction of plasma, transforming it into life-saving therapies, and distributing them worldwide to healthcare providers.
More about Grifols Sa's Market Share
|
Third Harmonic Bio Inc
Share Performance
-55.90%
One Year
|
Third Harmonic Bio Inc
Profile
Third Harmonic Bio Inc's business model centers around developing and commercializing innovative therapeutic solutions through the utilization of bioinformatics and genomics.
More about Third Harmonic Bio Inc 's Market Share
|
Immunome Inc
Share Performance
-4.89%
Over The Past 5 Days
|
Immunome Inc
Profile
Immunome Inc is a biotechnology company that focuses on developing novel immunotherapies. Their business model revolves around leveraging their proprietary discovery engine to identify therapeutic antibodies for infectious diseases and cancer. By collaborating with partners and through their own clinical development efforts, they aim to bring these promising treatments to the market.
More about Immunome Inc's Market Share
|
Kalvista Pharmaceuticals Inc
Share Performance
+6.39%
30 Days
|
Kalvista Pharmaceuticals Inc
Profile
Kalvista Pharmaceuticals Inc's business model primarily focuses on the development and commercialization of novel small molecule therapies for various diseases. They strive to discover and develop innovative treatments to address unmet medical needs, and aim to bring these therapies to market efficiently and effectively.
More about Kalvista Pharmaceuticals Inc 's Market Share
|
An2 Therapeutics Inc
Share Performance
-24.66%
This Quarter
|
An2 Therapeutics Inc
Profile
An2 Therapeutics Inc is a biotechnology company that develops therapeutics for the treatment of rare diseases. Their business model focuses on research and development of innovative drugs that target specific genetic mutations responsible for these rare conditions, aiming to provide effective and personalized treatments. By collaborating with pharmaceutical partners and leveraging their expertise in drug discovery, An2 Therapeutics Inc aims to bring their therapies to market and improve the lives of patients with rare diseases.
More about An2 Therapeutics Inc 's Market Share
|
Morphic Holding inc
Share Performance
+98.71%
This Quarter
|
Morphic Holding inc
Profile
Morphic Holding Inc's business model revolves around the development and commercialization of novel integrin therapeutics. They utilize a platform that combines structural biology, medicinal chemistry, and computational biology to design and develop small-molecule drugs. By strategically targeting and inhibiting integrin receptors, Morphic aims to address various diseases while offering potential benefits to patients.
More about Morphic Holding inc 's Market Share
|
Structure Therapeutics Inc
Share Performance
+0.23%
Over The Past 5 Days
|
Structure Therapeutics Inc
Profile
Structure Therapeutics Inc is a biotechnology company that utilizes a structure-based approach to develop innovative therapeutics. They focus on identifying and targeting unique protein structures to create novel drugs for various diseases.
More about Structure Therapeutics Inc 's Market Share
|
Mirati Therapeutics Inc
Share Performance
-0.14%
30 Days
|
Mirati Therapeutics Inc
Profile
Mirati Therapeutics Inc is a biotechnology company that focuses on the research, discovery, and development of precision oncology treatments for patients with cancer. Their business model involves leveraging their proprietary drug discovery platform to identify and develop targeted therapies, and collaborating with partners for the commercialization of their products.
More about Mirati Therapeutics Inc 's Market Share
|
Apellis Pharmaceuticals Inc
Share Performance
-0.51%
30 Days
|
Apellis Pharmaceuticals Inc
Profile
Apellis Pharmaceuticals Inc operates under a business model that focuses on the research, development, and commercialization of novel therapies for various medical conditions, with a particular emphasis on complement immunotherapy. They aim to bring innovative drugs to market that can positively impact patients' lives worldwide.
More about Apellis Pharmaceuticals Inc 's Market Share
|
Prometheus Biosciences Inc
Share Performance
+0.47%
Over The Past 5 Days
|
Prometheus Biosciences Inc
Profile
Prometheus Biosciences Inc is a biotechnology company that operates on a subscription-based business model. Their platform offers personalized diagnostic tools and services to healthcare providers, enabling them to deliver targeted treatments for patients with gastrointestinal diseases. By providing ongoing support and monitoring, Prometheus aims to improve patient outcomes and revolutionize the management of chronic conditions in the field of gastroenterology.
More about Prometheus Biosciences Inc 's Market Share
|
Bristol myers Squibb Company
Share Performance
+11.76%
One Year
|
Bristol myers Squibb Company
Profile
Bristol Myers Squibb Company operates a research and development-driven business model, focusing on the discovery and delivery of innovative medicines for various diseases. It emphasizes collaboration with academic institutions, government entities, and other pharmaceutical firms to enhance its therapeutic portfolio and improve patient outcomes.
More about Bristol myers Squibb Company's Market Share
|
Pfizer Inc
Share Performance
-9.92%
This Year
|
Pfizer Inc
Profile
Pfizer Inc operates as a global pharmaceutical company that focuses on researching, developing, manufacturing, and marketing innovative medicines. Its business model emphasizes significant investment in research and development to build a diverse portfolio of therapies across various therapeutic areas, while leveraging strategic alliances and collaborations to enhance commercialization and drive growth.
More about Pfizer Inc's Market Share
|
Sources: Transcode Therapeutics Inc and all companies mentioned above in this report
|
